跳至主要内容
临床试验/NCT01320475
NCT01320475终止4 期

Thoracic Epidural Analgesia: Epidural Levobupivacaine and Sufentanil Versus Epidural Levobupivacaine and Intravenous Ketamine

Hopital Foch1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2010年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
发起方
Hopital Foch
入组人数
2
试验地点
1
主要终点
Efficacy of the analgesic regimen

研究概览

简要总结

Thoracic epidural analgesia is often proposed to thoracotomized patients. A local anesthetic and an opioid are generally associated to produce an epidural analgesia. However, opioid epidural administration is frequently associated with adverse effects as nausea, vomiting, urinary retention, ... On the other hand, iv ketamine has been demonstrated to be an effective analgesic.

The purpose of the study is to compare the epidural administration of levobupivacaine and sufentanil or the epidural administration of levobupivacaine associated with the iv administration of ketamine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age between 18 and 75 yrs
  • class ASA I, II or III
  • lung surgery

排除标准

  • Contra-indication to the achievement of epidural analgesia
  • Preoperative chronic pain,
  • Contra-indication to ketamine
  • Hypersensitivity to ketamine or any excipients
  • Uncontrolled hypertension,
  • Heart failure
  • Hepatic porphyria
  • Contra-indication to sufentanil
  • Hypersensitivity to sufentanil, opioids or any excipients
  • Treatment with an opioid agonist-antagonist,
  • Contra-indication to levobupivacaine
  • Hypersensitivity to levobupivacaine, local anesthetics of the amide or any excipients
  • Hypotension, shock

研究组 & 干预措施

iv Ketamine

Experimental

Epidural infusion of levobupivacaine and saline (placebo for sufentanil)and iv infusion of ketamine Up to the third postoperative day (6 PM)

干预措施: Ketamine (Drug)

Sufentanil

Active Comparator

Epidural infusion of levobupivacaine (1,25 mg/ml) and sufentanil(1 ml = 50 µg diluted in the 200 ml bag of levobupivacaine) IV infusion of saline (placebo for ketamine)

干预措施: Sufentanil (Drug)

结局指标

主要结局

Efficacy of the analgesic regimen

时间窗: third postoperative day

Occurrence of an adverse event due to the analgesic protocol

时间窗: one week

次要结局

  • postoperative complications (pulmonary, others)(one month)
  • length of stay(one month)
  • patient's satisfaction(sortie de l'hopital)
  • Occurence of a chronic pain(end the first postoperative year)
  • postoperative rehabilitation(two weeks)

研究者

发起方
Hopital Foch
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验